ACEI/ARB
Sponsors
First Affiliated Hospital Xi'an Jiaotong University, University of Utah, Novartis Pharmaceuticals, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Beijing Friendship Hospital
Conditions
COVIDChronic Heart FailureHeart FailureHenoch Schönlein Purpura NephritisHypertensionMyocardial Infarction With Non-Obstructive Coronary ArteriesObesityPrimary Membranous Nephropathy
Phase 4
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
TerminatedNCT04491136
Start: 2020-11-11End: 2023-06-08Updated: 2025-05-16
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Active, not recruitingNCT05122780
Start: 2021-07-01End: 2025-07-31Updated: 2024-07-26
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
RecruitingNCT06573411
Start: 2024-09-30End: 2026-10-30Target: 116Updated: 2026-04-08
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
RecruitingNCT07315191
Start: 2025-06-13End: 2028-04-30Target: 116Updated: 2026-01-07
Unknown Phase
Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure
NCT03821701
Start: 2018-06-01End: 2022-01-31Target: 340Updated: 2019-08-07
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
CompletedNCT04467931
Start: 2020-01-19End: 2020-12-31Updated: 2021-04-28
A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data
CompletedNCT05096143
Start: 2020-06-03End: 2020-10-19Updated: 2021-12-21
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
RecruitingNCT05498675
Start: 2021-09-01End: 2027-06-30Target: 180Updated: 2025-02-13